Pfizer

cancer target detection radiopharma radio
Biotech

Nuvalent trots out strong pivotal data in FDA lung cancer push

Nuvalent is eyeing an FDA rolling submission for its ROS1 inhibitor in TKI-pretreated lung cancer after releasing competitive pivotal data.
Angus Liu Jun 24, 2025 6:30am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Pfizer CEO makes case for $6B bet on 'fabulous' bispecific

Jun 10, 2025 9:56am
Road closed and detour signs

FDA refuses Axsome filing for former Pfizer fibromyalgia asset

Jun 9, 2025 12:27pm
Alzheimers dementia brain memory loss

Pharma-backed dementia fund raises $269M to invest in therapies

May 20, 2025 9:48am
Heart-shaped diamond

Former Pfizer antibody reduces cardio risk marker in ph. 2

May 20, 2025 7:30am
hot

Pfizer pays 3SBio $1.25B for PD-1xVEGF bispecific

May 20, 2025 4:47am